Long‑term response to sequential treatment with tyrosine kinase inhibitors in a patient with EGFR+ adenocarcinoma – case report

01/2021

MUDr. Bc. Petr Zůna

Klinika pneumologie 3. LF UK a Nemocnice Na Bulovce, Praha

SUMMARY

Lung cancer is one of the tumours with very bad prognosis. Patients with epidermal growth factor receptor (EGFR) positive lung cancer are treated with tyrosine kinase inhibitors with good treatment tolerance and statistically significant improved survival outcome. Case report presents long survival of the 78 years old patient with EGFR positive non-small cell lung cancer on targeted therapy.

Key words

non-small cell lung cancer, EGFR